Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
26.7%
% of PBE's 30 holdings also in GNOM
19.5%
% of GNOM's 41 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
BIOMARIN PHARMACEUTICAL INC | 5.2% | 4.2% | 4.2% |
|
VERACYTE INC | 3.2% | 3.1% | 3.1% |
|
QIAGEN NV | 2.8% | 4.4% | 2.8% |
|
SAREPTA THERAPEUTICS INC | 2.8% | 4.0% | 2.8% |
|
GILEAD SCIENCES INC | 6.6% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to GNOM
|
BIOGEN IDEC INC | 7.3% |
|
REGENERON PHARMACEUTICALS | 6.0% |
|
AMGEN INC | 5.6% |
|
INCYTE CORP | 5.2% |
|
GILEAD SCIENCES INC | 4.2% |
|
REPLIGEN CORP | 3.7% |
|
HALOZYME THERAPEUTICS INC | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.3% |
|
UNITED THERAPEUTICS CORP | 3.1% |
|
NEUROCRINE BIOSCIENCES INC | 3.1% |
PBE Underweight Relative to GNOM
|
10X GENOMICS INC CLASS A | -5.1% |
|
AGILENT TECHNOLOGIES INC | -4.5% |
 |
BIONTECH SE SPONSORED ADR | -4.5% |
|
BIO-TECHNE CORPORATION | -4.5% |
|
ALNYLAM PHARMACEUTICALS INC | -4.2% |
|
CRISPR THERAPEUTICS AG | -4.0% |
|
INTELLIA THERAPEUTICS, INC. | -3.8% |
|
BEAM THERAPEUTICS, INC. | -3.7% |
|
ILLUMINA INC | -3.7% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.6% |